Case Report
Early-Onset Alzheimer’s Disease Masquerading as Catatonia
Table 1
Laboratory tests performed.
| Test | Result |
| Initial testing | Complete metabolic panel and liver function tests | Within normal limits | Complete blood count | Within normal limits | Urine analysis | Within normal limits | Thyroid-stimulating hormone | 0.97 (0.27–4.20) uIU/mL | Chest X-ray | Unremarkable | Urine toxicology | Amphetamines screen: negative | Barbiturates screen: negative | Cocaine screen: negative | Benzodiazepine screen: negative | THC screen: negative | Methadone: negative | Oxycodone screen: negative | Opiates screen: negative | Phencyclidine screen: negative | Secondary workup | HIV 1/2 rapid antibody | Nonreactive | Rapid plasma reagin | Negative | Sedimentation rate | 10 (0–20) mm/hr | C-reactive protein | <0.03 (<0.5) mg/dL | Autoimmune panel | Antinuclear antibody: negative | Antineutrophil cytoplasmic Ab: negative | C4, 29 (10–40) mg/dL | C3, 139 (90–180) mg/dL | SSA Ab <0.3 (0.0–6.9) U/mL | SSB Ab <0.3 (0.0–6.9) U/mL | Anti-DSDNA 7 (0–24) IU | Smith antibody 1.5 (0.0–6.9) U/mL | Anti-TPO: negative | Mayo dementia, autoimmune evaluation panel: negative | Cerebrospinal fluid studies | Color and clarity | Clear and colorless | White blood cells | 1 (0–10) mm3 | Red blood cell count | 1 mm3 | Protein | 19 (15–45) mg/dL | Glucose | 64 (40–70) mg/dL | Myelin basic protein | Negative | Oligoclonal bands | Negative | Cytology | No atypical lymphoid cells | Mayo paraneoplastic panel | Negative | Mayo dementia, autoimmune evaluation panel | Negative | Protein 14-3-3 | <0.2 | Neuronal specific enolase | Negative | VDRL | Negative |
|
|